MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$109,448K
Net Income
$8,054K
Net Profit Margin
7.36%
EPS
$0.15
Unit: Thousand (K) dollars
Revenue Breakdown
    • Prenatal
    • Oncology
    • Clinical Trial Support And Other...
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
109,448
108,388
54,543*
83,523
Cost of revenue
32,341
29,292
21,333*
25,107
Gross profit
77,107
79,096
33,210*
58,416
Research and development
17,315
14,692
10,525*
12,953
Selling, general and administrative
54,289
46,570
35,561*
35,830
Total operating expenses
71,604
61,262
46,086*
48,783
Income (gain) from operations
5,503
17,834
-12,876*
9,633
Interest income
4,694
4,645
3,145*
1,535
Interest expense
8
10
35*
20
Net gain on extinguishment of debt
-
-
0*
0
Change in fair value of term loan
-2,968
-4,261
3,299*
-3,936
Change in fair value of convertible notes
-
-
0*
0
Other income (expense), net
297
301
-2,520*
-1,630
Total other income (expense)
2,015
675
3,889*
-4,051
Income (gain) before provision for income taxes
7,518
18,509
-8,987*
5,582
Provision for income taxes
-536
539
692*
-129
Net income (gain)
8,054
17,970
-9,679*
5,711
Less net income (gain) attributable to participating securities
-
-
-8,077*
4,204
Net income (gain) attributable to common stockholders
-
-
-1,602
1,507
Net income (gain) attributable to common stockholders
-
-
-1,602
1,507
Comprehensive income (loss)
8,054
17,970
-
-
Basic EPS
0.17
0.39
-0.075
0.14
Diluted EPS
0.15
0.34
-0.06
0.1
Basic Average Shares
46,403,350
45,932,719
21,320,599
10,429,583
Diluted Average Shares
54,455,523
53,028,360
26,889,555
15,571,949
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Prenatal$94,248K Oncology$13,663K Clinical Trial SupportAnd Other Services$1,537K Revenue$109,448K Gross profit$77,107K Interest income$4,694K Cost of revenue$32,341K Other income(expense), net$297K Income (gain) fromoperations$5,503K Total other income(expense)$2,015K Total operatingexpenses$71,604K Change in fair value ofterm loan-$2,968K Interest expense$8K Income (gain) beforeprovision for income taxes$7,518K Provision for income taxes-$536K Selling, general andadministrative$54,289K Research and development$17,315K Net income (gain)$8,054K Comprehensive income (loss)$8,054K

BillionToOne, Inc. (BLLN)

BillionToOne, Inc. (BLLN)